You are here:

Forthcoming Submission: sarilumab (Kevzara)

Indication: In combination with methotrexate, or as monontherapy, for the treatment of moderately to severely active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs. Kevzara can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate.

Drug Details

Drug Name: sarilumab (Kevzara)
Drug Manufacturer: Sanofi Genzyme
BNF Category:
Submission type: Full submission
Patient Interest Group
Submission Deadline:
SMC Meeting Date: 6/03/2018
Advice Due: 9/04/2018